René Lindholm Cordtz

Medicine & Life Sciences

1. Rheumatoid Arthritis 100%
2. Cohort Studies 98%
3. Psoriatic Arthritis 81%
4. Antirheumatic Agents 76%
5. Denmark 71%
6. Tumor Necrosis Factor Inhibitors 69%
7. Interrupted Time Series Analysis 45%
8. Incidence 44%
9. Hip 36%
10. Registries 32%
11. Population 27%
12. Delivery of Health Care 27%
13. Knee Replacement Arthroplasties 25%
14. Hospitalization 24%
15. Replacement Arthroplasties 21%
16. Biological Products 21%
17. Systemic Lupus Erythematosus 20%
18. Arthritis 20%
19. Comorbidity 18%
20. Knee 17%
21. Biological Therapy 16%
22. Cutaneous Lupus Erythematosus 16%
23. Mortality 15%
24. Joints 15%
25. Infections 15%
26. Neoplasms 14%
27. Rheumatic Diseases 13%
28. Gout 13%
29. Wales 12%
30. Premature Mortality 12%
31. Second Primary Neoplasms 12%
32. Rheumatology 12%
33. Interstitial Lung Diseases 11%
34. Immunologic Factors 11%
35. Sweden 11%
36. Therapeutics 11%
37. England 10%
38. Psoriasis 10%
39. Methotrexate 10%
40. Respiratory Insufficiency 10%
41. Reoperation 10%
42. Lymphoma 9%
43. Upper Extremity 9%
44. Case-Control Studies 9%
45. Lung Diseases 9%
46. Calendars 9%
47. Pharmaceutical Preparations 9%
48. Vaccination 8%
49. Health Care Outcome Assessment 8%
50. Non-Hodgkin's Lymphoma 8%